Md. biotech Adaptive Phage Therapeutics advances fight to wipe out superbugs in cystic fibrosis


The National Institutes of Health is funding its latest clinical trial.

Previous Research breakdown: These faculty members helped UTHSC score a record $133M in research funds in FY 2022
Next Charlotte veterinary startup Petfolk using tech to disrupt its industry